Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics

Can Psychiatr Assoc J. 1973 Oct;18(5):377-83. doi: 10.1177/070674377301800505.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aminobutyrates / metabolism
  • Antipsychotic Agents / administration & dosage
  • Canada
  • Clinical Trials as Topic
  • Drug Synergism
  • Female
  • Hospitals, Psychiatric
  • Humans
  • Length of Stay
  • Male
  • Methionine / metabolism
  • Middle Aged
  • Nicotinic Acids / administration & dosage
  • Nicotinic Acids / adverse effects
  • Nicotinic Acids / therapeutic use*
  • Phenothiazines
  • Placebos
  • Psychiatric Status Rating Scales
  • Pyridoxine / administration & dosage
  • Pyridoxine / adverse effects
  • Pyridoxine / metabolism
  • Pyridoxine / therapeutic use*
  • Schizophrenia / drug therapy*
  • Tryptophan / metabolism

Substances

  • Aminobutyrates
  • Antipsychotic Agents
  • Nicotinic Acids
  • Phenothiazines
  • Placebos
  • Tryptophan
  • Methionine
  • Pyridoxine